AstraZeneca PLC
AZN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $8,691 | $6,899 | $2,501 | -$265 |
| Dep. & Amort. | $5,065 | $4,934 | $5,480 | $6,530 |
| Deferred Tax | $0 | $0 | -$619 | -$615 |
| Stock-Based Comp. | $0 | $579 | $619 | $615 |
| Change in WC | -$893 | $300 | $3,757 | $2,021 |
| Other Non-Cash | -$1,002 | -$2,367 | -$1,930 | -$2,323 |
| Operating Cash Flow | $11,861 | $10,345 | $9,808 | $5,963 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,924 | -$1,361 | -$2,571 | -$2,200 |
| Net Acquisitions | -$3,927 | -$1,179 | -$1,061 | -$9,433 |
| Inv. Purchases | -$96 | -$136 | -$159 | -$184 |
| Inv. Sales/Matur. | $108 | $129 | $42 | $105 |
| Other Inv. Act. | -$2,141 | -$1,517 | $789 | $654 |
| Investing Cash Flow | -$7,980 | -$4,064 | -$2,960 | -$11,058 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,809 | -$965 | -$1,197 | $7,894 |
| Stock Issued | -$43 | $33 | $29 | $29 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$4,629 | -$4,481 | -$4,364 | -$3,856 |
| Other Fin. Act. | -$1,133 | -$1,154 | -$1,291 | -$418 |
| Financing Cash Flow | -$3,996 | -$6,567 | -$6,823 | $3,649 |
| Forex Effect | -$93 | -$60 | -$80 | -$62 |
| Net Chg. in Cash | -$208 | -$346 | -$55 | -$1,508 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,637 | $5,983 | $6,038 | $7,546 |
| End Cash | $5,429 | $5,637 | $5,983 | $6,038 |
| Free Cash Flow | $7,275 | $6,567 | $7,237 | $3,763 |